Literature DB >> 3851848

Acylamino boronic acids and difluoroborane analogues of amino acids: potent inhibitors of chymotrypsin and elastase.

D H Kinder, J A Katzenellenbogen.   

Abstract

A series of 1-acylamino boronic acids (IA-VA), analogues of the amino acids phenylalanine, phenylglycine, alanine, valine, and isoleucine, were prepared as potential transition-state inhibitors of the serine proteases alpha-chymotrypsin and elastase, by a boronate homologation reaction. The corresponding difluoroboranes (IB-VB), produced from the boronic acids by treatment with HF, were more easily purified than the boronic acids. Since the difluoroboranes readily hydrolyze in water, they proved to be convenient precursors for the boronic acids. The phenylalanine and phenylglycine analogues I and II were good competitive inhibitors of alpha-chymotrypsin (Ki = 0.3-8 microM), and the alanine, valine, and isoleucine analogues (III-IV) proved to be good inhibitors of elastase (Ki = 0.1-35 microM). On the basis of their high affinity and the tendency of boronic acids to form borate complexes, these acylamino boronic acids may be behaving as transition-state inhibitors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3851848     DOI: 10.1021/jm00150a027

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Synthesis of amidomethyltrifluoroborates and their use in cross-coupling reactions.

Authors:  Gary A Molander; Marie-Aude Hiebel
Journal:  Org Lett       Date:  2010-11-05       Impact factor: 6.005

2.  A method for the deprotection of alkylpinacolyl boronate esters.

Authors:  Jing Sun; Michael T Perfetti; Webster L Santos
Journal:  J Org Chem       Date:  2011-04-07       Impact factor: 4.354

3.  Branched peptide boronic acids (BPBAs): a novel mode of binding towards RNA.

Authors:  Wenyu Zhang; David I Bryson; Jason B Crumpton; Jessica Wynn; Webster L Santos
Journal:  Chem Commun (Camb)       Date:  2013-03-25       Impact factor: 6.222

4.  HIV-1 drug discovery: targeting folded RNA structures with branched peptides.

Authors:  Jessica E Wynn; Webster L Santos
Journal:  Org Biomol Chem       Date:  2015-06-07       Impact factor: 3.876

5.  Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumor necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease and DNA fragmentation.

Authors:  S C Wright; Q S Wei; D H Kinder; J W Larrick
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

6.  Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity.

Authors:  S C Wright; U Schellenberger; H Wang; D H Kinder; J W Talhouk; J W Larrick
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

7.  Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation.

Authors:  S C Wright; Q S Wei; J Zhong; H Zheng; D H Kinder; J W Larrick
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

8.  Group-assisted purification (GAP) chemistry for the synthesis of Velcade via asymmetric borylation of N-phosphinylimines.

Authors:  Jian-Bo Xie; Jian Luo; Timothy R Winn; David B Cordes; Guigen Li
Journal:  Beilstein J Org Chem       Date:  2014-03-31       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.